nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—HTR1B—telencephalic ventricle—Parkinson's disease	0.0245	0.0971	CbGeAlD
Xylometazoline—HTR1D—telencephalic ventricle—Parkinson's disease	0.0237	0.094	CbGeAlD
Xylometazoline—ADRA2A—peripheral nervous system—Parkinson's disease	0.0112	0.0444	CbGeAlD
Xylometazoline—Oxymetazoline—HTR2A—Parkinson's disease	0.0112	1	CrCbGaD
Xylometazoline—ADRA1A—hindbrain—Parkinson's disease	0.00861	0.0341	CbGeAlD
Xylometazoline—ADRA1D—forebrain—Parkinson's disease	0.00829	0.0328	CbGeAlD
Xylometazoline—HTR1B—brainstem—Parkinson's disease	0.00664	0.0263	CbGeAlD
Xylometazoline—HTR1D—brainstem—Parkinson's disease	0.00642	0.0254	CbGeAlD
Xylometazoline—HTR1B—forebrain—Parkinson's disease	0.0064	0.0254	CbGeAlD
Xylometazoline—HTR1D—forebrain—Parkinson's disease	0.0062	0.0246	CbGeAlD
Xylometazoline—HTR1B—cardiovascular system—Parkinson's disease	0.00541	0.0214	CbGeAlD
Xylometazoline—HTR1D—cardiovascular system—Parkinson's disease	0.00524	0.0208	CbGeAlD
Xylometazoline—ADRA1A—brainstem—Parkinson's disease	0.00494	0.0195	CbGeAlD
Xylometazoline—ADRA1B—head—Parkinson's disease	0.00485	0.0192	CbGeAlD
Xylometazoline—ADRA1A—forebrain—Parkinson's disease	0.00476	0.0189	CbGeAlD
Xylometazoline—ADRA1D—head—Parkinson's disease	0.00475	0.0188	CbGeAlD
Xylometazoline—ADRA1B—nervous system—Parkinson's disease	0.0046	0.0182	CbGeAlD
Xylometazoline—ADRA1D—nervous system—Parkinson's disease	0.0045	0.0178	CbGeAlD
Xylometazoline—ADRA1B—central nervous system—Parkinson's disease	0.00443	0.0176	CbGeAlD
Xylometazoline—ADRA1D—central nervous system—Parkinson's disease	0.00433	0.0172	CbGeAlD
Xylometazoline—HTR1B—midbrain—Parkinson's disease	0.00423	0.0167	CbGeAlD
Xylometazoline—HTR1B—spinal cord—Parkinson's disease	0.00413	0.0163	CbGeAlD
Xylometazoline—HTR1D—midbrain—Parkinson's disease	0.00409	0.0162	CbGeAlD
Xylometazoline—ADRA1A—cardiovascular system—Parkinson's disease	0.00403	0.016	CbGeAlD
Xylometazoline—HTR1B—head—Parkinson's disease	0.00367	0.0145	CbGeAlD
Xylometazoline—ADRA2A—forebrain—Parkinson's disease	0.00362	0.0143	CbGeAlD
Xylometazoline—HTR1D—head—Parkinson's disease	0.00355	0.0141	CbGeAlD
Xylometazoline—ADRA1B—brain—Parkinson's disease	0.00352	0.0139	CbGeAlD
Xylometazoline—HTR1B—nervous system—Parkinson's disease	0.00348	0.0138	CbGeAlD
Xylometazoline—ADRA1D—brain—Parkinson's disease	0.00344	0.0136	CbGeAlD
Xylometazoline—HTR1D—nervous system—Parkinson's disease	0.00337	0.0133	CbGeAlD
Xylometazoline—HTR1B—central nervous system—Parkinson's disease	0.00335	0.0133	CbGeAlD
Xylometazoline—ADRA2C—medulla oblongata—Parkinson's disease	0.00328	0.013	CbGeAlD
Xylometazoline—HTR1D—central nervous system—Parkinson's disease	0.00324	0.0128	CbGeAlD
Xylometazoline—ADRA2C—midbrain—Parkinson's disease	0.003	0.0119	CbGeAlD
Xylometazoline—ADRA2C—spinal cord—Parkinson's disease	0.00292	0.0116	CbGeAlD
Xylometazoline—ADRA1A—head—Parkinson's disease	0.00273	0.0108	CbGeAlD
Xylometazoline—HTR1B—brain—Parkinson's disease	0.00266	0.0105	CbGeAlD
Xylometazoline—ADRA2A—medulla oblongata—Parkinson's disease	0.00262	0.0104	CbGeAlD
Xylometazoline—ADRA2C—head—Parkinson's disease	0.0026	0.0103	CbGeAlD
Xylometazoline—ADRA1A—nervous system—Parkinson's disease	0.00259	0.0102	CbGeAlD
Xylometazoline—HTR1D—brain—Parkinson's disease	0.00257	0.0102	CbGeAlD
Xylometazoline—ADRA1A—central nervous system—Parkinson's disease	0.00249	0.00986	CbGeAlD
Xylometazoline—ADRA2C—nervous system—Parkinson's disease	0.00246	0.00976	CbGeAlD
Xylometazoline—ADRA1A—cerebellum—Parkinson's disease	0.00243	0.00964	CbGeAlD
Xylometazoline—ADRA2A—midbrain—Parkinson's disease	0.00239	0.00947	CbGeAlD
Xylometazoline—ADRA2C—central nervous system—Parkinson's disease	0.00237	0.0094	CbGeAlD
Xylometazoline—ADRA2A—spinal cord—Parkinson's disease	0.00233	0.00924	CbGeAlD
Xylometazoline—ADRA2C—cerebellum—Parkinson's disease	0.00232	0.00918	CbGeAlD
Xylometazoline—ADRA2A—head—Parkinson's disease	0.00207	0.00821	CbGeAlD
Xylometazoline—ADRA1A—brain—Parkinson's disease	0.00198	0.00783	CbGeAlD
Xylometazoline—ADRA2A—nervous system—Parkinson's disease	0.00197	0.00779	CbGeAlD
Xylometazoline—ADRA2A—central nervous system—Parkinson's disease	0.00189	0.0075	CbGeAlD
Xylometazoline—ADRA2C—brain—Parkinson's disease	0.00188	0.00746	CbGeAlD
Xylometazoline—ADRA2A—cerebellum—Parkinson's disease	0.00185	0.00733	CbGeAlD
Xylometazoline—ADRA2A—brain—Parkinson's disease	0.0015	0.00595	CbGeAlD
Xylometazoline—ADRA2A—Signaling Pathways—GRM4—Parkinson's disease	0.000163	0.000222	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TAC1—Parkinson's disease	0.000163	0.000222	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—FGB—Parkinson's disease	0.000163	0.000222	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000163	0.000221	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—EDN1—Parkinson's disease	0.000163	0.000221	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR1A—Parkinson's disease	0.000162	0.000221	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—GRM5—Parkinson's disease	0.000162	0.00022	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—TAC1—Parkinson's disease	0.000162	0.00022	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—EDN1—Parkinson's disease	0.000162	0.00022	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GFAP—Parkinson's disease	0.000161	0.000219	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD1—Parkinson's disease	0.00016	0.000218	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TAC1—Parkinson's disease	0.00016	0.000217	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GRM5—Parkinson's disease	0.00016	0.000217	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD1—Parkinson's disease	0.000159	0.000216	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000158	0.000215	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD1—Parkinson's disease	0.000157	0.000213	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000157	0.000213	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD3—Parkinson's disease	0.000155	0.000211	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAG—Parkinson's disease	0.000155	0.00021	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PENK—Parkinson's disease	0.000155	0.00021	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000155	0.00021	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD3—Parkinson's disease	0.000154	0.000209	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000153	0.000208	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000153	0.000208	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PLA2G6—Parkinson's disease	0.000153	0.000207	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	0.000153	0.000207	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—FGF20—Parkinson's disease	0.000152	0.000207	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD3—Parkinson's disease	0.000152	0.000206	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—EDN1—Parkinson's disease	0.000151	0.000205	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MAOB—Parkinson's disease	0.000151	0.000205	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—INSR—Parkinson's disease	0.000151	0.000205	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	0.00015	0.000204	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	0.00015	0.000204	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—EDN1—Parkinson's disease	0.000149	0.000202	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ADORA2A—Parkinson's disease	0.000148	0.000201	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—EDN1—Parkinson's disease	0.000147	0.0002	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ADRBK1—Parkinson's disease	0.000145	0.000197	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000144	0.000195	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	0.000143	0.000195	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—FGB—Parkinson's disease	0.000143	0.000194	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HTR2A—Parkinson's disease	0.000142	0.000193	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—FGF20—Parkinson's disease	0.000142	0.000193	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR1A—Parkinson's disease	0.000142	0.000193	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	0.000142	0.000193	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000142	0.000193	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PDYN—Parkinson's disease	0.000142	0.000193	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000142	0.000192	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000142	0.000192	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD2—Parkinson's disease	0.00014	0.000191	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HTR7—Parkinson's disease	0.00014	0.000191	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—FGF20—Parkinson's disease	0.00014	0.00019	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TAC1—Parkinson's disease	0.00014	0.00019	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD2—Parkinson's disease	0.000139	0.000189	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HTR7—Parkinson's disease	0.000139	0.000189	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CYP2D6—Parkinson's disease	0.000138	0.000188	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ADORA2A—Parkinson's disease	0.000138	0.000187	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR7—Parkinson's disease	0.000137	0.000187	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD2—Parkinson's disease	0.000137	0.000187	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—EDN1—Parkinson's disease	0.000137	0.000186	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD1—Parkinson's disease	0.000137	0.000186	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—INSR—Parkinson's disease	0.000136	0.000185	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ADORA2A—Parkinson's disease	0.000136	0.000184	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CTGF—Parkinson's disease	0.000136	0.000184	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—EDN1—Parkinson's disease	0.000135	0.000183	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GFAP—Parkinson's disease	0.000133	0.000181	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD3—Parkinson's disease	0.000133	0.00018	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000132	0.00018	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000132	0.000179	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GRM5—Parkinson's disease	0.000132	0.000179	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00013	0.000177	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—FGB—Parkinson's disease	0.000129	0.000175	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000129	0.000175	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR1A—Parkinson's disease	0.000128	0.000174	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—INSR—Parkinson's disease	0.000127	0.000173	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CYP2E1—Parkinson's disease	0.000126	0.000172	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TAC1—Parkinson's disease	0.000126	0.000171	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000126	0.000171	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—INSR—Parkinson's disease	0.000125	0.00017	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—NQO1—Parkinson's disease	0.000125	0.00017	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	0.000124	0.000169	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ADRBK1—Parkinson's disease	0.000124	0.000168	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD1—Parkinson's disease	0.000124	0.000168	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—TH—Parkinson's disease	0.000123	0.000167	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000123	0.000167	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000121	0.000164	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—FGB—Parkinson's disease	0.00012	0.000163	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD2—Parkinson's disease	0.00012	0.000163	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR7—Parkinson's disease	0.00012	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HTR2A—Parkinson's disease	0.00012	0.000163	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	0.00012	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD3—Parkinson's disease	0.00012	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR1A—Parkinson's disease	0.00012	0.000163	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—FGB—Parkinson's disease	0.000118	0.000161	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CYCS—Parkinson's disease	0.000118	0.000161	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000118	0.00016	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TAC1—Parkinson's disease	0.000118	0.00016	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR1A—Parkinson's disease	0.000118	0.00016	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IGF2—Parkinson's disease	0.000118	0.00016	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TAC1—Parkinson's disease	0.000116	0.000158	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD1—Parkinson's disease	0.000116	0.000157	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000116	0.000157	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—FGF20—Parkinson's disease	0.000116	0.000157	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IGF2—Parkinson's disease	0.000115	0.000156	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD1—Parkinson's disease	0.000114	0.000155	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IGF1R—Parkinson's disease	0.000114	0.000154	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EDN1—Parkinson's disease	0.000112	0.000153	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CYP2D6—Parkinson's disease	0.000112	0.000153	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ADORA2A—Parkinson's disease	0.000112	0.000152	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD3—Parkinson's disease	0.000112	0.000152	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000112	0.000152	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—EDN1—Parkinson's disease	0.000111	0.000151	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	0.000111	0.000151	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	0.000111	0.000151	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CTGF—Parkinson's disease	0.00011	0.00015	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD3—Parkinson's disease	0.00011	0.00015	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	0.00011	0.000149	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR7—Parkinson's disease	0.000108	0.000147	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD2—Parkinson's disease	0.000108	0.000147	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000107	0.000146	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	0.000105	0.000143	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000105	0.000143	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—COMT—Parkinson's disease	0.000105	0.000142	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	0.000105	0.000142	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ADRBK1—Parkinson's disease	0.000105	0.000142	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—GSTP1—Parkinson's disease	0.000104	0.000142	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—MAOA—Parkinson's disease	0.000104	0.000141	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	0.000103	0.00014	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NGF—Parkinson's disease	0.000103	0.00014	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	0.000103	0.00014	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000103	0.00014	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—HMOX1—Parkinson's disease	0.000103	0.00014	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	0.000103	0.000139	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—NQO1—Parkinson's disease	0.000102	0.000138	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD2—Parkinson's disease	0.000101	0.000138	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR7—Parkinson's disease	0.000101	0.000138	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	0.000101	0.000137	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NGF—Parkinson's disease	0.000101	0.000137	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IGF2—Parkinson's disease	0.000101	0.000137	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—TH—Parkinson's disease	0.0001	0.000136	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	9.96e-05	0.000135	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	9.96e-05	0.000135	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ABCB1—Parkinson's disease	9.87e-05	0.000134	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	9.83e-05	0.000133	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	9.79e-05	0.000133	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	9.77e-05	0.000133	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	9.75e-05	0.000132	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	9.73e-05	0.000132	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	9.72e-05	0.000132	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	9.62e-05	0.000131	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	9.61e-05	0.000131	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CYCS—Parkinson's disease	9.61e-05	0.000131	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—GSTM1—Parkinson's disease	9.58e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	9.57e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	9.39e-05	0.000128	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—GPX1—Parkinson's disease	9.18e-05	0.000125	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	9.14e-05	0.000124	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—APOE—Parkinson's disease	9.13e-05	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	9.09e-05	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	9.08e-05	0.000123	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—APOE—Parkinson's disease	8.94e-05	0.000121	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	8.85e-05	0.00012	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	8.85e-05	0.00012	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	8.83e-05	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	8.78e-05	0.000119	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	8.68e-05	0.000118	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—COMT—Parkinson's disease	8.51e-05	0.000116	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	8.49e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	8.48e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GSTP1—Parkinson's disease	8.47e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—MTHFR—Parkinson's disease	8.47e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MAOA—Parkinson's disease	8.45e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	8.41e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—HMOX1—Parkinson's disease	8.35e-05	0.000113	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	8.35e-05	0.000113	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	8.22e-05	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	8.22e-05	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	8.2e-05	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	8.11e-05	0.00011	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	8.07e-05	0.00011	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ABCB1—Parkinson's disease	8.02e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	7.98e-05	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	7.97e-05	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—APOE—Parkinson's disease	7.88e-05	0.000107	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	7.82e-05	0.000106	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—INS—Parkinson's disease	7.8e-05	0.000106	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GSTM1—Parkinson's disease	7.78e-05	0.000106	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—INS—Parkinson's disease	7.64e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	7.59e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GPX1—Parkinson's disease	7.45e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	7.45e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	7.42e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	7.33e-05	9.96e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	7.17e-05	9.74e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	7.09e-05	9.63e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	7.09e-05	9.62e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	7.06e-05	9.59e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	6.98e-05	9.48e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	6.89e-05	9.36e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MTHFR—Parkinson's disease	6.88e-05	9.34e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—INS—Parkinson's disease	6.74e-05	9.15e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—INS—Parkinson's disease	6.68e-05	9.07e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	6.66e-05	9.05e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	6.59e-05	8.95e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	6.58e-05	8.94e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	6.51e-05	8.84e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	6.49e-05	8.81e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—APOE—Parkinson's disease	6.4e-05	8.7e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	6.2e-05	8.42e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	6.05e-05	8.22e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—INS—Parkinson's disease	6.03e-05	8.19e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	5.81e-05	7.89e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	5.77e-05	7.84e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	5.76e-05	7.83e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	5.76e-05	7.82e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	5.69e-05	7.73e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	5.65e-05	7.68e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—INS—Parkinson's disease	5.63e-05	7.65e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—INS—Parkinson's disease	5.54e-05	7.53e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—INS—Parkinson's disease	5.47e-05	7.43e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	5.35e-05	7.27e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	5.34e-05	7.25e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	5.23e-05	7.1e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	4.97e-05	6.75e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	4.94e-05	6.71e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—INS—Parkinson's disease	4.92e-05	6.69e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—INS—Parkinson's disease	4.57e-05	6.21e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	4.57e-05	6.21e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	4.49e-05	6.1e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	4.46e-05	6.06e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	4.19e-05	5.7e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	4.17e-05	5.66e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	4.13e-05	5.61e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	4.13e-05	5.6e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	4.1e-05	5.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	3.85e-05	5.23e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	3.79e-05	5.15e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	3.67e-05	4.98e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	3.64e-05	4.95e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL6—Parkinson's disease	3.41e-05	4.63e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	3.41e-05	4.63e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	3.38e-05	4.6e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	3.37e-05	4.58e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL6—Parkinson's disease	3.34e-05	4.53e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	3.13e-05	4.25e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	2.92e-05	3.96e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	2.63e-05	3.58e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	2.46e-05	3.34e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	2.42e-05	3.29e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	2.15e-05	2.92e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	2e-05	2.71e-05	CbGpPWpGaD
